KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Bristol Myers Squibb (BMY) Operating Expenses (2016 - 2025)

Historic Operating Expenses for Bristol Myers Squibb (BMY) over the last 17 years, with Q3 2025 value amounting to $9.1 billion.

  • Bristol Myers Squibb's Operating Expenses fell 1084.57% to $9.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $40.0 billion, marking a year-over-year decrease of 2635.37%. This contributed to the annual value of $56.7 billion for FY2024, which is 5500.46% up from last year.
  • Per Bristol Myers Squibb's latest filing, its Operating Expenses stood at $9.1 billion for Q3 2025, which was down 1084.57% from $10.5 billion recorded in Q2 2025.
  • In the past 5 years, Bristol Myers Squibb's Operating Expenses registered a high of $23.4 billion during Q1 2024, and its lowest value of $8.2 billion during Q1 2025.
  • Its 5-year average for Operating Expenses is $10.4 billion, with a median of $9.8 billion in 2023.
  • Its Operating Expenses has fluctuated over the past 5 years, first surged by 17291.93% in 2024, then crashed by 6480.05% in 2025.
  • Over the past 5 years, Bristol Myers Squibb's Operating Expenses (Quarter) stood at $10.1 billion in 2021, then dropped by 5.73% to $9.5 billion in 2022, then grew by 2.68% to $9.8 billion in 2023, then rose by 24.12% to $12.2 billion in 2024, then dropped by 25.14% to $9.1 billion in 2025.
  • Its Operating Expenses was $9.1 billion in Q3 2025, compared to $10.5 billion in Q2 2025 and $8.2 billion in Q1 2025.